| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
AMLX
Amylyx Pharmaceuticals Inc
|
Oct 16, 2025 | BUY |
Strong Buy
+46.8% avg upside
13 analysts
|
$19.00
21.31% Upside
|
+1.3% |
|
LRMR
Larimar Therapeutics
|
Sep 30, 2025 | BUY |
Strong Buy
+413.5% avg upside
21 analysts
|
$7.00
92.39% Upside
|
+5.3% |
|
ACAD
ACADIA Pharmaceuticals
|
Sep 24, 2025 | BUY |
Strong Buy
+66.0% avg upside
42 analysts
|
$31.00
43.30% Upside
|
+1.6% |
|
DNTH
Dianthus Therapeutics
|
Sep 09, 2025 | BUY |
Strong Buy
+8.9% avg upside
29 analysts
|
$67.00
18.84% Downside
|
+121.8% |
|
PTCT
PTC Therapeutics
|
Aug 08, 2025 | BUY |
Strong Buy
-1.4% avg upside
29 analysts
|
$70.00
11.39% Downside
|
+73.0% |
|
JAZZ
Jazz Pharmaceuticals
|
Aug 07, 2025 | BUY |
Strong Buy
-1.8% avg upside
35 analysts
|
$160.00
28.80% Downside
|
+105.7% |
|
ARGX
Argenx Se
|
Aug 01, 2025 | BUY |
Strong Buy
-15.9% avg upside
46 analysts
|
$788.00
10.30% Downside
|
+31.0% |
|
TSE:FURY
Fury Gold Mines
|
Jun 26, 2025 | BUY |
Strong Buy
+385.8% avg upside
4 analysts
|
— | · |
|
AXSM
Axsome Therapeutics
|
Jun 10, 2025 | BUY |
Strong Buy
-10.5% avg upside
28 analysts
|
$157.00
37.40% Downside
|
+124.1% |
|
NGNE
Neurogene
|
May 16, 2025 | HOLD |
Strong Buy
+55.9% avg upside
23 analysts
|
$24.00
23.97% Downside
|
+65.8% |
|
EDIT
Editas Medicine
|
May 13, 2025 | BUY |
Buy
+420.3% avg upside
33 analysts
|
$4.00
48.64% Upside
|
+93.3% |
|
DNLI
Denali Therapeutics
|
May 08, 2025 | BUY |
Strong Buy
+60.2% avg upside
24 analysts
|
$29.00
24.44% Upside
|
+36.0% |
|
PRAX
Praxis Precision Medicines
|
May 05, 2025 | BUY |
Strong Buy
+92.1% avg upside
24 analysts
|
$76.00
73.13% Downside
|
+755.5% |
|
ALKS
Alkermes
|
May 02, 2025 | BUY |
Strong Buy
-17.5% avg upside
34 analysts
|
$41.00
8.83% Downside
|
+5.0% |
|
DFTX
Definium Therapeutics
|
Mar 07, 2025 | BUY |
Strong Buy
+45.0% avg upside
20 analysts
|
$16.00
34.61% Downside
|
+158.6% |
|
CTNM
Contineum Therapeutics, Inc. Class A
|
Mar 07, 2025 | BUY |
Strong Buy
+70.7% avg upside
8 analysts
|
$16.00
33.93% Upside
|
+105.0% |
|
CPRX
Catalyst Pharma
|
Mar 03, 2025 | BUY |
Strong Buy
-17.0% avg upside
15 analysts
|
$32.00
1.93% Upside
|
+7.2% |
|
INMB
Inmune Bio
|
Feb 24, 2025 | HOLD |
Buy
+753.7% avg upside
11 analysts
|
— | -83.2% |
|
CYPH
Cypherpunk Technologies
|
Feb 24, 2025 | HOLD |
Buy
+1087.0% avg upside
9 analysts
|
— | · |
|
DRUG
Bright Minds Biosciences
|
Nov 25, 2024 | BUY |
Strong Buy
+120.9% avg upside
10 analysts
|
$75.00
23.54% Upside
|
+69.8% |
|
CLDI
Calidi Biotherapeutics
|
Nov 17, 2024 | BUY |
Strong Buy
+6314.1% avg upside
3 analysts
|
$2.50
1380.18% Upside
|
-94.7% |
|
IMMP
Immutep
|
Nov 14, 2024 | BUY |
Strong Buy
+1343.0% avg upside
7 analysts
|
$7.00
1770.61% Upside
|
-11.5% |
|
NRIX
Nurix Therapeutics
|
Jul 11, 2024 | BUY |
Strong Buy
+76.3% avg upside
26 analysts
|
$26.00
48.07% Upside
|
-43.5% |
|
ARCT
Arcturus Therapeutics
|
May 10, 2024 | HOLD |
Buy
+291.8% avg upside
35 analysts
|
— | -59.7% |
|
GERN
Geron
|
May 02, 2024 | HOLD |
Strong Buy
+240.0% avg upside
19 analysts
|
$4.50
257.19% Upside
|
-65.1% |
|
ARWR
Arrowhead Pharmaceuticals
|
Jan 05, 2024 | HOLD |
Strong Buy
-19.1% avg upside
26 analysts
|
— | -44.4% |
|
SNDX
Syndax Pharmaceuticals
|
Jan 05, 2024 | HOLD |
Strong Buy
+88.7% avg upside
27 analysts
|
— | -33.1% |
|
COGT
Cogent Biosciences
|
Dec 12, 2023 | BUY |
Strong Buy
+7.4% avg upside
26 analysts
|
$14.00
59.55% Downside
|
+87.4% |
|
BYSI
Beyondspring
|
Nov 07, 2023 | BUY |
Hold
+400.8% avg upside
8 analysts
|
$1.25
22.44% Downside
|
+95.4% |
|
RARE
Ultragenyx Pharmaceutical
|
Nov 02, 2023 | BUY |
Strong Buy
+142.0% avg upside
36 analysts
|
$57.00
107.81% Upside
|
+39.3% |
|
BMRN
BioMarin Pharmaceutical
|
Nov 01, 2023 | BUY |
Strong Buy
+72.7% avg upside
52 analysts
|
$127.00
132.18% Upside
|
-20.7% |
|
PLRX
Pliant Therapeutics
|
Sep 26, 2023 | BUY |
Buy
+1820.7% avg upside
21 analysts
|
$44.00
3693.09% Upside
|
-33.0% |
|
CRDF
Cardiff Oncology
|
Sep 26, 2023 | BUY |
Strong Buy
+736.8% avg upside
18 analysts
|
$5.00
313.25% Upside
|
+70.4% |
|
VAXX
Vaxxinity Inc
|
Sep 07, 2023 | BUY |
Buy
+73233.3% avg upside
4 analysts
|
$7.00
46566.63% Upside
|
-98.3% |
|
IDYA
IDEAYA Biosciences
|
Nov 17, 2022 | BUY |
Strong Buy
+55.3% avg upside
29 analysts
|
$24.00
23.13% Downside
|
+67.1% |
|
VIR
Vir Biotechnology
|
Aug 09, 2022 | HOLD |
Strong Buy
+185.4% avg upside
16 analysts
|
$25.00
172.94% Upside
|
-53.2% |
|
KYNB
Kyntra Bio
|
Mar 02, 2021 | BUY |
Buy
+369.6% avg upside
14 analysts
|
$51.00
661.16% Upside
|
-64.8% |
|
ALNY
Alnylam Pharma
|
Feb 12, 2021 | HOLD |
Strong Buy
+23.4% avg upside
51 analysts
|
$175.00
37.10% Downside
|
-4.5% |
|
VNDA
Vanda
|
Feb 11, 2021 | HOLD |
Strong Buy
+253.1% avg upside
13 analysts
|
$18.00
210.39% Upside
|
-27.6% |
|
SRPT
Sarepta Therapeutics
|
Jan 12, 2021 | HOLD |
Buy
+246.5% avg upside
49 analysts
|
$108.00
516.05% Upside
|
-15.3% |
|
HALO
Halozyme
|
Dec 11, 2020 | HOLD |
Strong Buy
-13.7% avg upside
20 analysts
|
$41.00
40.13% Downside
|
-16.0% |
|
AMRN
Amarin
|
Dec 07, 2020 | BUY |
Buy
-47.2% avg upside
18 analysts
|
$7.00
56.28% Downside
|
-27.4% |
|
IONS
Ionis Pharmaceuticals
|
Sep 08, 2020 | BUY |
Strong Buy
+13.3% avg upside
43 analysts
|
$74.00
0.19% Downside
|
-29.9% |
|
MIRM
Mirum Pharmaceuticals
|
Sep 01, 2020 | BUY |
Strong Buy
+7.5% avg upside
21 analysts
|
$31.00
71.07% Downside
|
· |
|
DBVT
DBV Technologies SA - American
|
Aug 05, 2020 | BUY |
Strong Buy
+55.4% avg upside
15 analysts
|
$4.00
74.34% Downside
|
+89.9% |
|
ELOX
Eloxx Pharmaceuticals
|
Jun 10, 2020 | HOLD |
Strong Buy
+153.9% avg upside
8 analysts
|
$4.00
71.42% Downside
|
-46.1% |
|
NERV
Minerva Neurosciences
|
Jun 01, 2020 | BUY |
Buy
+68.3% avg upside
8 analysts
|
$6.00
34.23% Upside
|
-29.4% |
|
TPST
Tempest Therapeutics
|
May 29, 2020 | BUY |
Buy
+1662.1% avg upside
18 analysts
|
$6.00
387.77% Upside
|
-55.3% |
|
XFOR
X4 Pharmaceuticals
|
May 18, 2020 | BUY |
Strong Buy
+496.4% avg upside
15 analysts
|
$14.00
231.78% Upside
|
-16.4% |
|
ESPR
Esperion
|
May 07, 2020 | BUY |
Buy
+701.2% avg upside
22 analysts
|
$56.00
1677.78% Upside
|
-49.5% |
|
MDGL
Madrigal Pharmaceuticals
|
Mar 05, 2020 | BUY |
Strong Buy
-5.8% avg upside
31 analysts
|
$155.00
69.43% Downside
|
+27.6% |
|
INO
Inovio Pharmaceuticals
|
Sep 15, 2019 | BUY |
Buy
+808.5% avg upside
19 analysts
|
$4.00
258.71% Upside
|
+406.7% |
|
ATYR
aTyr Pharma
|
Aug 30, 2019 | HOLD |
Buy
+2016.8% avg upside
17 analysts
|
$3.75
732.46% Upside
|
+34.0% |
|
SLDB
Solid Biosciences
|
Aug 29, 2019 | SELL |
Strong Buy
+92.3% avg upside
23 analysts
|
$6.00
28.06% Downside
|
+71.9% |
|
IBRX
ImmunityBio
|
May 30, 2019 | SELL |
Strong Buy
+55.2% avg upside
12 analysts
|
$0.80
89.19% Downside
|
-529.9% |
|
KURA
Kura Oncology
|
May 24, 2019 | BUY |
Strong Buy
+162.8% avg upside
26 analysts
|
$25.00
151.79% Upside
|
-1.7% |
|
NVAX
Novavax
|
May 06, 2019 | BUY |
Buy
+154.0% avg upside
20 analysts
|
$19.00
108.05% Upside
|
+86.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.